Name | Myostatin-IN-1 |
---|
Description | Myostatin-IN-1 is a potent myostatin inhibitor (IC50 of 0.19, 0.63, 0.89 and 1.6 μM for myostatin, GDF-11, activin A and TGF-β1, respectively). Myostatin-IN-1 increases the tibialis anterior muscle mass in mice. Myostatin-IN-1 can be used for researching the prolonged inactivation of myostatin in skeletal muscle[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.19 μM (myostatin), 0.63 μM (GDF-11), 0.89 μM (activin A), 1.6 μM (TGF-β1)[1] |
In Vitro | Myostatin-IN-1 (MID-35) (50 µM; 400 min) possesses complete proteolytic stability, and can survive 99 and 97% of the intact form incubated for 400 min in trypsin or α-chymotrypsin solution[1]. |
In Vivo | Myostatin-IN-1 (0.75 mM; i.m.; single) can significantly induce the increase in tibialis anterior (TA) muscle mass in C57BL/6J mice[1]. Animal Model: C57BL/6J mice (8 weeks)[1] Dosage: 0.75 mM Administration: i.m.; single Result: Significantly induced the increase in tibialis anterior (TA) muscle mass in C57BL/6J mice. |
References |
Molecular Formula | C118H184N34O17 |
---|---|
Molecular Weight | 2350.94 |